20861622

Source:http://linkedlifedata.com/resource/pubmed/id/20861622

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0085826, umls-concept:C0205178, umls-concept:C0442027, umls-concept:C0521116, umls-concept:C0948008, umls-concept:C1280500, umls-concept:C1521828, umls-concept:C2917212
pubmed:issue	5
pubmed:dateCreated	2010-10-12
pubmed:abstractText	Our goal is to assess if current antiplatelet (AP) use has an effect on recanalization rate and outcome in acute stroke patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9100851
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/Warfarin, http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel
pubmed:status	MEDLINE
pubmed:issn	1421-9786
pubmed:author	pubmed-author:Al-HussainFawazF, pubmed-author:AlexandrovAndrei VAV, pubmed-author:CLOTBUST Investigators, pubmed-author:DemchukAndrew MAM, pubmed-author:HussainMuhammadM, pubmed-author:IbrahimMohamed MMM, pubmed-author:KhanKhurshidK, pubmed-author:MolinaCarlosC, pubmed-author:SaqqurMaherM, pubmed-author:SebastianJosephJ, pubmed-author:UchinoKenK
pubmed:copyrightInfo	Copyright © 2010 S. Karger AG, Basel.
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	508-13
pubmed:meshHeading	pubmed-meshheading:20861622-Administration, Oral, pubmed-meshheading:20861622-Aged, pubmed-meshheading:20861622-Aged, 80 and over, pubmed-meshheading:20861622-Anticoagulants, pubmed-meshheading:20861622-Aspirin, pubmed-meshheading:20861622-Drug Therapy, Combination, pubmed-meshheading:20861622-Female, pubmed-meshheading:20861622-Fibrinolytic Agents, pubmed-meshheading:20861622-Humans, pubmed-meshheading:20861622-Injections, Intravenous, pubmed-meshheading:20861622-Male, pubmed-meshheading:20861622-Middle Aged, pubmed-meshheading:20861622-Platelet Aggregation Inhibitors, pubmed-meshheading:20861622-Prospective Studies, pubmed-meshheading:20861622-Retrospective Studies, pubmed-meshheading:20861622-Stroke, pubmed-meshheading:20861622-Thrombolytic Therapy, pubmed-meshheading:20861622-Ticlopidine, pubmed-meshheading:20861622-Tissue Plasminogen Activator, pubmed-meshheading:20861622-Treatment Outcome, pubmed-meshheading:20861622-Warfarin
pubmed:year	2010
pubmed:articleTitle	Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
pubmed:affiliation	Department of Medicine (Neurology), University of Alberta, 8440 112th Avenue, Edmonton, AB, Canada.
pubmed:publicationType	Journal Article, Multicenter Study